Coastal Bridge Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.7M Sell
68,834
-232
-0.3% -$30.6K 0.54% 42
2026
Q1
$9.63M Sell
69,066
-550
-0.8% -$77K 0.68% 38
2025
Q4
$8.54M Buy
69,616
+27,096
+64% +$3.29M 0.64% 38
2025
Q3
$4.72M Sell
42,520
-93
-0.2% -$10.6K 0.36% 71
2025
Q2
$4.72M Buy
42,613
+9
+0% +$958 0.39% 66
2025
Q1
$4.77M Buy
+42,604
New +$4.4M 0.43% 59

Other funds holding GILD

Coastal Bridge Advisors's GILD Position: Q2 2026 in Review

Coastal Bridge Advisors reduced its Gilead Sciences (GILD) stake by 0.34% in Q2 2026, selling an estimated $30.6K and leaving 68,834 shares worth $8.7M. The position accounts for 0.54% of the portfolio, ranked #42.

Coastal Bridge Advisors first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $9.63M in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Coastal Bridge Advisors held 68,834 shares of Gilead Sciences worth $8.7M as of Q2 2026.
  • Coastal Bridge Advisors sold 232 Gilead Sciences shares in Q2 2026, an estimated $30.6K.
  • Gilead Sciences made up 0.54% of Coastal Bridge Advisors's portfolio in Q2 2026, its #42 holding.
  • Coastal Bridge Advisors first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
  • Coastal Bridge Advisors's Gilead Sciences position peaked at $9.63M in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Coastal Bridge Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.